Search

In Stock

Buy Ilumya (tildrakizumab) Online

DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Almirall, S.A.

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.

This product is currently out of stock and unavailable.

Compare

Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.

Uses

Ilumya is used to treat moderate to severe plaque psoriasis in adults. Plaque psoriasis is a chronic autoimmune disease that causes red, scaly patches of skin to form. Ilumya can help to clear these patches and improve the appearance and comfort of the skin.

Storage Conditions

Ilumya should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze. Ilumya can be kept at room temperature for up to 24 hours.

Mechanism of Action

Ilumya is a monoclonal antibody that binds to the p19 subunit of IL-23 and blocks its interaction with the IL-23 receptor. IL-23 is a cytokine that plays a key role in the development and progression of psoriasis. By blocking IL-23, Ilumya can help to reduce inflammation and improve the symptoms of psoriasis.

How to Use

Ilumya is administered by subcutaneous injection every 12 weeks. The recommended dose is 100 mg. Ilumya should be injected by a healthcare professional.

Important Safety Information

Ilumya can increase the risk of serious infections, including tuberculosis. Before starting Ilumya, your doctor will test you for tuberculosis. Ilumya can also reactivate latent tuberculosis infection.

Ilumya can also increase the risk of other side effects, such as:

  • Allergic reactions
  • Inflammatory bowel disease (IBD)
  • Psoriasis worsening
  • Injection site reactions
  • Upper respiratory tract infections
  • Headache
  • Diarrhea
  • Nausea
  • Fatigue

Indications

Ilumya is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Precautions

Ilumya should be used with caution in patients with a history of serious infections, tuberculosis, IBD, or other autoimmune diseases.

Ilumya should not be used in patients who have a history of severe allergic reactions to Ilumya or other biologic medications.

Interactions

Ilumya may interact with other medications, including live vaccines and biologic medications. Be sure to tell your doctor about all of the medications you are taking before starting Ilumya.

Contraindications

Ilumya is contraindicated in patients with a history of severe allergic reactions to Ilumya or other biologic medications.

Overdose

There is no known overdose of Ilumya.

Side Effects

The most common side effects of Ilumya are upper respiratory tract infections, headache, diarrhea, nausea, fatigue, and injection site reactions.

More serious side effects of Ilumya include serious infections, IBD, psoriasis worsening, and allergic reactions.

If you experience any side effects while taking Ilumya, be sure to tell your doctor.

Package

One syringe of 100 mg/ml

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Skyrizi (Risankizumab) Online

From $14,517.47
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: AbbVie Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) Skyrizi (risankizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Skilarence (dimethyl fumarate) Online

From $93.21
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Skilarence (dimethyl fumarate) is a prescription medication used to treat moderate to severe plaque psoriasis in adults. It is an oral medication that works by suppressing the immune system and reducing inflammation.

Buy Takhzyro (lanadelumab) Online

$14,055.70
(0 Reviews)
DISEASE INDICATIONS: Hereditary angioedema (HAE) MANUFACTURER: Shire Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Takhzyro (lanadelumab) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. HAE is a rare genetic disorder that causes episodes of swelling in the face, throat, abdomen, hands, and feet. These episodes can be life-threatening.

Buy Cibinqo (abrocitinib) Online

From $1,287.82
(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Pfizer Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Medicines & Healthcare products Regulatory Agency (MHRA) Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.

Buy Adbry (tralokinumab-ldrm) Online

(0 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Leo Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Adbry (tralokinumab-ldrm) is a fully human monoclonal antibody that neutralizes the activity of interleukin-13 (IL-13), a cytokine that plays a key role in the pathogenesis of atopic dermatitis. Adbry is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older.

Back to Top
Product has been added to your cart